Our experimental models, whereby we observed functional dichotomy in Abi3-mediated immunoproteostasis in Aβ and tau models, allow us to impute the probable function of the ABI3 risk variant in influencing AD risk. This evidence concerns the gene ABI3 and Alzheimer disease.